Clinical Trial Update: Preoperative Octreotide Treatment of Acromegaly [Phase 4]

View source ↗

Summary

This update notes the completion of a Phase 4 clinical trial evaluating preoperative octreotide treatment in patients with acromegaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Octreotide (Sandostatin) (Octreotide)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Acromegaly | Phase 4 | Status: COMPLETED